FDA inspection
Endonovo Therapeutics, Inc.: FDA inspection ending Oct 31, 2025
FDA inspection 1289500 · Voluntary Action Indicated (VAI) · Woodland Hills, CA
Key facts
| Inspection ID | 1289500 |
|---|---|
| Firm | Endonovo Therapeutics, Inc. |
| FEI number | 3014308816 |
| Address | 6320 Canoga Ave Fl 15 |
| City | Woodland Hills |
| State | CA |
| ZIP | 91367 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Oct 31, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data